Pharmacy Times August 4, 2022
Exploring the significant role of electronic medical records (EMR) in toxicity management for patients with HR+/HER2– breast cancer.
Ryan Haumschild, PharmD, MS, MBA: Speaking of ways that we can create good standards and predictability in terms of medication ordering, as pharmacists, the [EMR] is a tool that we utilize from providers to make sure as we’re verifying that we’re looking at treatment parameters. Dr Moore, talk to us a little about how you leverage your electronic medical record EMR and how it plays into the treatment paradigm of patients with breast cancer.
Heather N. Moore, PharmD, BCOP, CPP: We certainly utilize our EMR, especially for our intravenous [IV] therapies and chemotherapy, ensuring that certain parameters are met, that we have...